SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Operating Income | ₹72 Cr | ₹76 Cr | ₹239 Cr | ₹239 Cr |
What is the latest Revenue of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹72 Cr |
| Mar2025 | ₹76 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹239 Cr |
How is Revenue of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹72 Cr | -5.00 | |
| Mar2025 | ₹76 Cr | -68.36 | |
| Mar2024 | ₹239 Cr | 0.00 | |
| Mar2023 | ₹239 Cr | - | |
Compare Revenue of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,907.0 Cr | 2.3% | -23.3% | 44.7% | Stock Analytics | |
| PRIME FOCUS | ₹22,409.2 Cr | -3.8% | 18.2% | 101% | Stock Analytics | |
| SAGILITY | ₹20,410.6 Cr | -0.8% | 7% | -6.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,286.0 Cr | 0.5% | -2.9% | -43.9% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,369.8 Cr | -2.5% | 4.1% | -8.5% | Stock Analytics | |
| INDEGENE | ₹13,348.3 Cr | 1.8% | 11.7% | 1.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 2.3% |
-23.3% |
44.7% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses